Get ready for a transition into value over the next 2 weeks. The confirmation for this breakout is a close above the upper trend line of the double bottom (59.24), with above average volume (50ML). Regardless of the exact day to enter this week of 9/28, current entry point ($57.32 9/25 close) is fantastic with little historical risk on the down side below $60 anyhow. Once this bullish pattern is confirmed CVS will at least hit $70 by 11/20/2020, historically CVS gains +-20% from the end of September to the end of November. CVS fundamentals are impeccable: book value = 110B vs 75B = market cap, P/E 9, EPS 2.26, 15B cash on hand. CVS is the largest pharmacy in the US. Seventy percent of the U.S. population lives within three minutes of a CVS store. CVS fair value is $92 updated on August 9th by Morningstar. For an options play I would pile up the November 20th Calls while they're still on discount. Good luck and happy trading friends.
Note
I don't know why after I submitted my words, it auto filled random in coherent things. This is what I typed: "" Get ready for a transition into value over the next 2 weeks. The confirmation for this breakout is a close above the upper trend line of the double bottom (59.24), with above average volume (50ML). Regardless of the exact day to enter this week of 9/28, current entry point ($57.32 9/25 close) is fantastic with little historical risk on the down side below $60 anyhow. Once this bullish pattern is confirmed CVS will at least hit $70 by 11/20/2020, historically CVS gains +-20% from the end of September to the end of November. CVS fundamentals are impeccable: book value = 110B vs 75B = market cap, P/E 9, EPS 2.26, 15B cash on hand. CVS is the largest pharmacy in the US. Seventy percent of the U.S. population lives within three minutes of a CVS store. CVS fair value is $92 updated on August 9th by Morningstar . For an options play I would pile up the November 20th Calls while they're still on discount. Good luck and happy trading friends.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.